Auraptene: A natural biologically active compound with multiple targets

Current Drug Targets

Volumn 12, Issue 3, 2011, Pages 381-386

  Genovese, Salvatore ^a   Epifano, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Anti cancer activity; Anti inflammatory activity; Cancer chemoprevention; Citrus; Edible plants; Prenyloxycoumarins; Rutaceae

Indexed keywords

ACETYLCHOLINESTERASE; ASCORBIC ACID; AURAPTENE; BETA CYCLODEXTRIN; CYTOCHROME P450; DAUNORUBICIN; GELATINASE A; GELATINASE B; GENISTEIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; MATRILYSIN; METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UMBELLIFERONE; VERAPAMIL;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER PREVENTION; CARCINOGENESIS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOMA; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; ESOPHAGUS TUMOR; HUMAN; IC 50; IMMUNOMODULATION; LARGE INTESTINE CANCER; LIVER CARCINOMA; LUNG METASTASIS; NONHUMAN; PROSTATE ADENOCARCINOMA; SKIN CANCER; TONGUE CARCINOMA;

EID: 79551621245     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945011794815248     Document Type: Article

References (34)

1. Curini M, Cravotto G, Epifano F, Giannone G. Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Curr Med Chem 2006; 13: 199-222.
2. Epifano F, Genovese S, Curini M. In: T. Matsumoto, Ed. Phytochemistry Research Progress USA: Nova Science Publishers Inc., Hauppauge 2008; pp. 145-62.
3. Murakami A, Kuki W, Takahashi Y, et al. Auraptene, a citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes. Jpn J Cancer Res 1997; 88: 443-52.
4. Giles D, Wei H. Effect of structurally related flavones/isoflavones on hydrogen peroxide production and oxidative DNA damage in phorbol ester-stimulated HL-60 cells. Nutr Cancer 1997; 29: 77-82
5. Soltani F, Mosaffa F, Iranshahi M, et al. Auraptene from Ferula szowitsiana protects human peripheral lymphocytes against oxidative stress. Phytotherapy Res 2010; 24: 85-9
6. Tanaka T, Kawabata K, Kakumoto M, et al. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats. Carcinogenesis 1998; 19: 425-31.
7. Tanaka T, Kawabata K, Kakumoto M, et al. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 1998; 58: 2550-6.
8. Kawabata K, Tanaka T, Yamamoto T, et al. Suppression of Nnitrosomethylbenzylamine-induced rat esophageal tumorigenesis by dietary feeding of auraptene. J Exp Clin Cancer Res 2000; 19: 45-52.
9. Sakata K, Hara A, Hirose Y, et al. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamineinduced rat hepatocarcinogenesis. Oncology 2004; 66: 244-52.
10. Kohno H, Suzuki R, Curini M, et al. Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice. Int J Cancer 2006; 118: 2936-42.
11. Tanaka T, de Azevedo MBM, Duran N, et al. Colorectal chemoprevention by 2 β-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid. Int J Cancer 2010; 126: 830-40.
12. Tanaka T, Sugiura H, Inaba R, et al. Immunomodulatory action of citrus auraptene on macrophage function and cytokine production of lymphocytes in female BALB/c mice. Carcinogenesis 1999; 8: 1471-6.
13. Tang M, Ogawa K, Asamoto M, et al. Effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and humane prostate carcinoma cells. Cancer Sci 2007; 98: 471-7.
14. Krishnan P, Yan KJ, Windler D, et al. Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats. BCM Cancer 2009; 9: 259-71.
15. Jun DY, Kim JS, Park HS, et al. Apoptogenic activity of auraptene of Zanthoxylum schinifolium towards human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase 8 activation that stimulates mitochondria-dependent or independent caspase cascade. Carcinogenesis 2007; 28: 1303-13.
16. Kawabata K, Murakami A, Ohigashi H. Auraptene decreases the activity of matrix metalloproteinases in dextran sulfate sodiuminduced ulcerative colitis in ICR mice. Biosci Biotech Biochem 2006; 70: 3062-5.
17. Kawabata K, Murakami A, Ohigashi H. Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism. FEBS Lett 2006; 580: 5288-94.
18. Hara A, Sakata K, Yamada Y, et al. Suppression of β-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats. Oncology Rep 2005; 14: 345-51.
19. Nabekura T, Yamaki T, Kitagawa S. Effects of chemopreventive citrus phytochemicals on human P-glycoprotein and multidrug resistance protein 1. Eur J Pharmacol 2008; 600: 45-9.
20. Murakami A, Nakamura Y, Tanaka T, et al. Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: role of leukocyte activation. Carcinogenesis 2000; 21: 1843-50.
21. Murakami A, Shigemori T, Ohigashi H. Zingiberaceous and citrus constituents, 1'-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action. J Nutr 2005; 135: 2987S-92.
22. Murakami A, Ohigashi H. Cancer-preventive anti-oxidants that attenuate free radical generation by inflammatory cells. Biol Chem 2006; 387, 387-92.
23. Murakami A. In: Yoshikawa T. Ed. Food Factors for Health Promotion. Forum Nutr. Basel Karger 2009; pp. 193-203.
24. Kleiner HE, Xia X, Sonoda Y, et al. Effects of natural coumarins on hepatic drug-metabolizing enzymes in mice. Toxicol Appl Pharmacol 2008; 232: 337-50.
25. Zhang DD. Mechanistic studies of the Nrf2-keap 1signaling pathway. Drug Metab Rev 2006; 38: 769-89.
26. Prince M, Li Y, Childers A, et al. Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice. Toxicol Lett 2009; 185: 180-6.
27. Kersten PS, Desvergne B, Wahli W. Roles of PPARs in health and disease. Nature 2000; 405: 421-4.
28. Kuronayagi K, Kang MS, Goto T, et al. Citrus auraptene act as an agonist for PPARs and enhances adiponectin production and MCP- 1 reduction in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2008; 366: 219-25.
29. Takahashi, N, Kang MS, Kuronayagi K, et al. Auraptene, a citrus fruit compound, regulates gene expression as a PPARalpha agonist in HepG2 hepatocytes. Biofactors 2008, 33: 25-32.
30. Pajvani UB, Hawkins M, Combs TP, et al. Complex distribution, not absolute amount of adiponectin correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-62.
31. Miyazawa M, Tougo H, Ishihara M. Inhibition of acetylcholinesterase activity by essential oil from Citrus paradisii. Nat Prod Lett 2001; 15: 205-10.
32. Masuda T, Muroya Y, Nakatani N. Coumarin constituents of the juice oil from Citrus hassaku and their spasmolytic activity. Biosci Biotech Bioche 1992; 56: 1257-60.
33. Kakiuchi N, Senaratne LRE, Huang SL, et al. Effects of constituents of Beli (Aegle marmelos) on spontaneous beating and calcium-paradox of myocardial cells. Planta Med 1991; 57: 43-6.
34. Kazunori O, Kawasaki A, Yoshida T, et al. Evaluation of auraptene content in Citrus fruits and their products. J Agric Food Chem 2000; 48: 1763-9.